These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18205713)

  • 1. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?
    Schallreuter KU; Bahadoran P; Picardo M; Slominski A; Elassiuty YE; Kemp EH; Giachino C; Liu JB; Luiten RM; Lambe T; Le Poole IC; Dammak I; Onay H; Zmijewski MA; Dell'Anna ML; Zeegers MP; Cornall RJ; Paus R; Ortonne JP; Westerhof W
    Exp Dermatol; 2008 Feb; 17(2):139-40; discussion 141-60. PubMed ID: 18205713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.
    Boissy RE; Spritz RA
    Exp Dermatol; 2009 Jul; 18(7):583-5. PubMed ID: 19320739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of vitiligo.
    Malhotra N; Dytoc M
    J Cutan Med Surg; 2013; 17(3):153-72. PubMed ID: 23673299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an autoimmune pathogenesis of vitiligo.
    Ongenae K; Van Geel N; Naeyaert JM
    Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo.
    Zhou J; An X; Dong J; Wang Y; Zhong H; Duan L; Ling J; Ping F; Shang J
    FASEB J; 2018 Sep; 32(9):4899-4916. PubMed ID: 29613836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the etiopathomechanism of vitiligo: a convergence theory.
    Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W
    Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity.
    Yu T; Wu Y; Lu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):147-151. PubMed ID: 38678613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.
    Ben Ahmed M; Zaraa I; Rekik R; Elbeldi-Ferchiou A; Kourda N; Belhadj Hmida N; Abdeladhim M; Karoui O; Ben Osman A; Mokni M; Louzir H
    Pigment Cell Melanoma Res; 2012 Jan; 25(1):99-109. PubMed ID: 21985183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors.
    Patel S; Rauf A; Khan H; Meher BR; Hassan SSU
    Biomed Pharmacother; 2017 Aug; 92():501-508. PubMed ID: 28575807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and immune system in vitiligo and thyroid diseases.
    Colucci R; Dragoni F; Moretti S
    Oxid Med Cell Longev; 2015; 2015():631927. PubMed ID: 25838868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review.
    Białczyk A; Wełniak A; Kamińska B; Czajkowski R
    Mol Diagn Ther; 2023 Nov; 27(6):723-739. PubMed ID: 37737953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo puzzle: the pieces fall in place.
    Westerhof W; d'Ischia M
    Pigment Cell Res; 2007 Oct; 20(5):345-59. PubMed ID: 17850508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo.
    Kovacs SO
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):647-66; quiz 667-8. PubMed ID: 9591808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.